Here, we highlight the importance of cancer cell–extrinsic regulation of the tumour microenvironment by demonstrating that activation of D2R signalling in tumour-associated endothelial cells by D2R agonists inhibits tumour angiogenesis and reduces chemotherapy-refractory SCLC growth. This evidence concerns the gene DRD2 and neoplasm.